PET-Adapted Nivolumab or Nivolumab Plus ICE As First Salvage Therapy in Relapsed or Refractory Hodgkin Lymphoma

ASH 2019: Results of a study examining Nivolumab as salvage therapy before autologous stem cell transplant in treating relaped Hodgkin lymphoma.